UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

Arthritis research & therapy, 2013-10, Vol.15 (5), p.R171-R171

2013

Link zum Volltext

Verfügbarkeit prüfen

Do encourage your scleroderma patients at risk to get influenza vaccine

Rheumatology (Oxford, England), 2018-10, Vol.57 (10), p.1691-1692

Kapetanovic, Meliha C

2018

Link zum Volltext

Verfügbarkeit prüfen

Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study

Arthritis & rheumatology (Hoboken, N.J.), 2021-07, Vol.73 (7), p.1135-1144

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice

Arthritis research & therapy, 2015-12, Vol.17 (379), p.378-378, Article 378

2015

Link zum Volltext

Verfügbarkeit prüfen

The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis

Arthritis research & therapy, 2012-07, Vol.14 (4), p.R170-R170

2012

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden

Rheumatology (Oxford, England), 2019-02, Vol.58 (2), p.227-236

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

Arthritis research & therapy, 2014-01, Vol.16 (1), p.R2-R2

2014

Link zum Volltext

Verfügbarkeit prüfen

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

Arthritis research & therapy, 2013-01, Vol.15 (1), p.R1-R1

2013

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine

Vaccine, 2017-02, Vol.35 (6), p.903-908

2017

Link zum Volltext

Verfügbarkeit prüfen

Further evidence for influenza and pneumococcal vaccination in patients treated with disease modifying antirheumatic drugs and anti-tumor necrosis factor agents

Journal of rheumatology, 2014-04, Vol.41 (4), p.626

Kapetanovic, Meliha C

2014

Link zum Volltext

Verfügbarkeit prüfen

Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden

Rheumatology (Oxford, England), 2020-01, Vol.59 (1), p.205-212

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register

Annals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1515

2017

Link zum Volltext

Verfügbarkeit prüfen

The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project

Arthritis research & therapy, 2020-10, Vol.22 (1), p.1-244, Article 244

2020

Link zum Volltext

Verfügbarkeit prüfen

Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study

Journal of rheumatology, 2015-05, Vol.42 (5), p.741

2015

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients

Scientific reports, 2021-04, Vol.11 (1), p.9199-9199, Article 9199

2021

Link zum Volltext

Verfügbarkeit prüfen

Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis

Frontiers in immunology, 2023, Vol.14, p.1203506-1203506

2023

Link zum Volltext

Verfügbarkeit prüfen

Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

Arthritis research & therapy, 2020-02, Vol.22 (1), p.36-36, Article 36

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis

Rheumatology (Oxford, England), 2018-04, Vol.57 (4), p.625-630

2018

Link zum Volltext

Verfügbarkeit prüfen

The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden

Arthritis research & therapy, 2018-08, Vol.20 (1), p.190-190, Article 190

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and incidence of non-gout crystal arthropathy in southern Sweden

Arthritis research & therapy, 2019-12, Vol.21 (1), p.291-291, Article 291

2019

Link zum Volltext

Verfügbarkeit prüfen

Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden

Journal of rheumatology, 2016-06, Vol.43 (6), p.1017

2016

Link zum Volltext

Verfügbarkeit prüfen

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies

Clinical rheumatology, 2017-12, Vol.36 (12), p.2743-2750

2017

Link zum Volltext

Verfügbarkeit prüfen

Cause‐Specific Mortality in Gout: Novel Findings of Elevated Risk of Non–Cardiovascular‐Related Deaths

Arthritis & rheumatology (Hoboken, N.J.), 2019-11, Vol.71 (11), p.1935-1942

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

Journal of rheumatology, 2005-07, Vol.32 (7), p.1213

2005

Link zum Volltext

Verfügbarkeit prüfen

Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors

Rheumatology (Oxford, England), 2023-10

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(69)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(57)
Medicin Och Hälsovetenskap
(55)
Medical And Health Sciences
(54)
Rheumatology
(54)
Clinical Medicine
(52)
Reumatologi Och Inflammation
(52)
Rheumatology And Autoimmunity
(52)
Klinisk Medicin
(51)
Humans
(48)
Female
(37)
Male
(36)
Middle Aged
(33)
Adult
(28)
Antirheumatic Agents - Therapeutic Use
(26)
Rheumatoid Arthritis
(26)
Aged
(21)
Arthritis, Rheumatoid - Drug Therapy
(21)
Vaccination
(18)
Arthritis
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

Do encourage your scleroderma patients at risk to get influenza vaccine

Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study

Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice

The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis

Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine

Further evidence for influenza and pneumococcal vaccination in patients treated with disease modifying antirheumatic drugs and anti-tumor necrosis factor agents

Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register

The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project

Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study

Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients

Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis

Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis

The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden

Prevalence and incidence of non-gout crystal arthropathy in southern Sweden

Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies

Cause‐Specific Mortality in Gout: Novel Findings of Elevated Risk of Non–Cardiovascular‐Related Deaths

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors

Suchergebnisse filtern